Table 3.
Effect of maternal age in childhood solid cancers development.
Diagnosis | Maternal age | N | Unadjusted OR | CI 95% | Adjusted OR ∗ | CI 95% |
---|---|---|---|---|---|---|
Brain tumor | All ages | 62 | p-value=0.99 a | p-value=0.97 | ||
| ||||||
<20 | 5 | 1.06 | 0.32-3.46 | 1.06 | 0.71-1.55 | |
| ||||||
20-24 | 16 | 2.06 | 0.80-5.29 | 1.92 | 0.27-4.16 | |
| ||||||
25-29b | 14 | 1 | 1 | |||
| ||||||
30-34 | 18 | 2.10 | 0.83-5.27 | 1.42 | 0.53-3.08 | |
| ||||||
>35 | 9 | 1.26 | 0.44-3.55 | 0.88 | 0.26-2.97 | |
| ||||||
Non-Hodgkin lymphoma | All ages | 43 | p-value=0.56 | p-value=0.80 | ||
| ||||||
<20 | 1 | 0.33 | 0.03-3.08 | 0.45 | 0.34-4.50 | |
| ||||||
20-24 | 11 | 1.29 | 0.47-3.51 | 1.53 | 0.54-4.30 | |
| ||||||
25-29b | 13 | 1 | 1 | |||
| ||||||
30-34 | 13 | 1.69 | 0.63-4.48 | 1.61 | 0.50-4.57 | |
| ||||||
>35 | 5 | 1.00 | 0.29-3-37 | 0.91 | 0.22-3.81 | |
| ||||||
Osteosarcoma | All ages | 42 | p-value=0.019 | p-value=0.054 | ||
| ||||||
<20 | 3 | 0.85 | 0.34-2.56 | 0.60 | 0.40-3.09 | |
| ||||||
20-24 | 16 | 0.70 | 0.24-2.04 | 0.58 | 0.16-2.08 | |
| ||||||
25-29b | 10 | 1 | 1 | |||
| ||||||
30-34 | 8 | 1.38 | 0.52-3.64 | 0.99 | 0.62-2.30 | |
| ||||||
>35 | 5 | 1.91 | 1.12-3.09 | 1.35 | 0.81-2.33 | |
| ||||||
Wilms tumor | All ages | 35 | p-value=0.954 | p-value=0.346 | ||
| ||||||
<20 | 1 | - | - | |||
| ||||||
20-24 | 10 | 2.47 | 0.73-8.39 | 2.76 | 0.75-10.17 | |
| ||||||
25-29b | 5 | 1 | 1 | |||
| ||||||
30-34 | 9 | 3.71 | 0.96-14.30 | 3.18 | 0.73-13.83 | |
| ||||||
>35 | 10 | 1.52 | 0.43-5.39 | 0.91 | 0.22-3.73 | |
| ||||||
Ewing's sarcoma | All ages | 24 | p-value=0.713 | p-value=0.543 | ||
| ||||||
<20 | 2 | 0.78 | 0.11-5.26 | 0.65 | 0.07-5.35 | |
| ||||||
20-24 | 7 | 1.24 | 0.32-4.76 | 1.51 | 0.31-7.37 | |
| ||||||
25-29b | 7 | 1 | 1 | |||
| ||||||
30-34 | 3 | 0.35 | 0-07-1.60 | 2.73 | 0.51-1.33 | |
| ||||||
>35 | 5 | 1.46 | 0.26-8.11 | 1.05 | 0.18-6.06 | |
| ||||||
Soft tissue sarcoma | All ages | 24 | p-value=0.567 | p-value=0.33 | ||
| ||||||
<20 | 0 | |||||
| ||||||
20-24 | 6 | 1.58 | 0.31-8.01 | 1.40 | 0.26-7.39 | |
| ||||||
25-29b | 7 | 1 | 1 | |||
| ||||||
30-34 | 6 | 0.92 | 0.24-3.47 | 1.45 | 0.29-7.09 | |
| ||||||
>35 | 5 | 2.04 | 0.47-8.78 | 1.59 | 0.45-8.59 | |
| ||||||
Gonadal germinal tumor | All ages | 21 | p-value: 0.15 | p-value=0.54 | ||
| ||||||
<20 | 1 | |||||
| ||||||
20-24 | 8 | 2.03 | 0.33-12.38 | 2.45 | 0.28-20.88 | |
| ||||||
25-29b | 3 | 1 | 1 | |||
| ||||||
30-34 | 6 | 1.92 | 0.25-14.3 | 1.37 | 0.17-10.94 | |
| ||||||
>35 | 3 | 0.85 | 0.11-6.12 | 0.76 | 0.09-6.37 | |
| ||||||
Retinoblastoma | All ages | 16 | p-value=0.04 | p-value=0.037 | ||
| ||||||
<20 | 0 | |||||
| ||||||
20-24 | 5 | 2.30 | 0.29-4.83 | 0.26 | 0.20-3.53 | |
| ||||||
25-29b | 3 | 1 | 1 | |||
| ||||||
30-34 | 3 | 1.00 | 0.47-5.28 | 1.09 | 0.41-4.07 | |
| ||||||
>35 | 5 | 1.51 | 0.67-8.19 | 1.21 | 1.09-6.08 | |
| ||||||
Hepatoblastoma | All ages | 16 | p-value= 0.587 | p-value=0.07 | ||
| ||||||
<20 | 1 | 0.54 | 0.03-8.10 | - | ||
| ||||||
20-24 | 2 | 0.55 | 0.05-5.67 | 1.02 | 0.07-14-12 | |
| ||||||
25-29b | 3 | 1 | 1 | |||
| ||||||
30-34 | 4 | 0.84 | 0.14-4.89 | 1.91 | 0.23-15.31 | |
| ||||||
>35 | 6 | 1.27 | 0.25-6.31 | 4.35 | 0.31-60.38 | |
| ||||||
Hodgkin lymphoma | All ages | 14 | p-value=0.192 | p-value=0.196 | ||
| ||||||
<20 | 2 | 5.08 | 0.34-75.08 | 5.58 | 0.20-14.93 | |
| ||||||
20-24 | 6 | 2.40 | 0.37-15.71 | 1.87 | 0.26-13.41 | |
| ||||||
25-29b | 2 | 1 | 1 | |||
| ||||||
30-34 | 4 | 2.89 | 0.35-23.39 | 1.03 | 0.08-13.10 | |
| ||||||
>35 | 0 | |||||
| ||||||
Neuroblastoma | All ages | 12 | p-value=0.898 | p-value=0.51 | ||
| ||||||
<20 | 1 | - | - | |||
| ||||||
20-24 | 1 | - | - | |||
| ||||||
25-29b | 5 | 1 | 1 | |||
| ||||||
30-34 | 4 | 0.66 | 0.054-8-07 | 1.91 | 0.24-15.10 | |
| ||||||
>35 | 1 | - | 0.76 | 0.04-14.02 |
∗ Adjusted by paternal age, number of siblings, and level of maternal and paternal education.
Significant results are bolded.
a denotes where age groups are taken to be continuous in all cancers.
b denotes reference group.